Carregant...

Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients

BACKGROUND: Ingenol mebutate (IM), a novel agent for field therapy of actinic keratosis (AK), has a drawback of inducing local skin reactions (LSRs), which may cause discomfort in patients. To reduce the LSRs, we tried the application of IM in low amounts. OBJECTIVE: The purpose of this study was to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cosmet Investig Dermatol
Autors principals: Joe, Hyun Jae, Oh, Byung Ho
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384689/
https://ncbi.nlm.nih.gov/pubmed/28408848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S129072
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!